http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LU-86464-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf8da2da8c87c78a55f5eb3608b95174 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 1986-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb4319bd01847e62638825f3ac3e51c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_873d5ee3103afd9f9b81b0dca8da7914 |
| publicationDate | 1986-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | LU-86464-A1 |
| titleOfInvention | FLOATING THERAPEUTIC COMPOSITIONS WITH PROGRESSIVE RELEASE |
| abstract | Compsn. is in the form of non-compressed tablet unit doses of density less than 1, so that it floats in the gastric fluid, in vivo. The tablets comprise a matrix formed from a gelling agent (I), contg. a therapeutic agent (II); a therapeutically acceptable inert oil (III) and water. (I) is 0.5-4% (III) is 8-30%; (II) is 50-75% and the balance water (all by wt.). Pref. (I) is theophylline (Ia) (a bronchodilator for treating asthma); (II) is gelose and (III) a light mineral oil of density 0.828-0.880. |
| priorityDate | 1986-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.